Strategic Investment
HCLTech Completes ₹1,427.25 Crore Investment in Sarvam AI, Acquires 10.46% Stake
NSE
hcltech
BSE
532281
HCL Technologies Limited has completed its previously announced investment of ₹1,427.25 crore in Axonwise Private Limited (Sarvam AI), acquiring a 10.46% stake through subscription to Series B2 Compulsory Convertible Preference Shares (CCPS). The allotment was completed on June 25, 2026.
PRICE-SENSITIVE TRIGGER
Event: Completion of strategic investment in Axonwise Private Limited (Sarvam AI).
Type: Strategic Investment
Impact: Positive
Immediate Effect: HCLTech has completed the acquisition of a 10.46% stake in Sarvam AI through subscription to 41,421 Series B2 Compulsory Convertible Preference Shares. The investment has been fully executed and the CCPS have been allotted.
Key Metrics:
- Investment Amount: ₹1,427.25 crore
- Stake Acquired: 10.46%
- Instrument: 41,421 Series B2 Compulsory Convertible Preference Shares (Series B2 CCPS)
- Investment Completion Date: June 25, 2026
- Event Time: 6:00 PM (IST)
Highlight:
- HCLTech has successfully completed its ₹1,427.25 crore strategic investment in Sarvam AI, securing a 10.46% ownership stake.
What Happened ?
HCL Technologies Limited announced the completion of its investment in Axonwise Private Limited (Sarvam AI), following its earlier disclosure dated June 15, 2026.
The company invested ₹1,427.25 crore by subscribing to 41,421 Series B2 Compulsory Convertible Preference Shares (CCPS) issued by Sarvam AI. These securities were allotted to HCLTech on June 25, 2026, completing the acquisition of a 10.46% stake.
The subscribed Series B2 CCPS will be converted into equity shares at a later date in accordance with their terms.
Key Details
Investment Details:
- HCLTech has completed the previously announced investment in Sarvam AI.
- Total investment amounts to ₹1,427.25 crore.
- Investment was made through subscription to 41,421 Series B2 Compulsory Convertible Preference Shares (CCPS).
- The investment represents a 10.46% stake in Sarvam AI.
- Series B2 CCPS were allotted on June 25, 2026.
- The CCPS will convert into equity shares at a future date as per applicable terms.
- The company confirmed the acquisition was completed on June 25, 2026, with the event recorded at 6:00 PM IST.
Note:
- This announcement confirms the completion of a transaction that was initially disclosed by HCLTech on June 15, 2026, marking the formal closing of its strategic investment in India’s AI ecosystem.
Risk Analysis
Summary:
- While the investment has been completed, the long-term value realization depends on Sarvam AI’s business execution, growth trajectory and future conversion of the preference shares into equity.
Key Risks:
- Returns depend on Sarvam AI’s future business performance.
- The investment is currently held through compulsorily convertible preference shares pending conversion.
- Strategic benefits will materialize over the longer term rather than immediately.
- AI industry competition and technology evolution could influence investment outcomes.
Worst Case:
- If Sarvam AI fails to achieve expected commercial growth or strategic milestones, the financial and strategic returns from the investment may fall below expectations.
Risk Level: Medium
Company Commentary
- HCLTech confirmed that the investment of ₹1,427.25 crore has been completed.
- The company subscribed to 41,421 Series B2 CCPS issued by Sarvam AI.
- The preference shares were allotted on June 25, 2026.
- The acquisition of the 10.46% stake has been completed.
- The subscribed CCPS will be converted into equity shares at a later date.
Official Exchange Filing: HCL Technologies Limited
